Barriers and Facilitators to Physical Activity for People With Scleroderma: A Scleroderma Patient-Centered Intervention Network Cohort Study.
Journal
Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
22
12
2020
received:
16
07
2020
accepted:
28
01
2021
pubmed:
3
2
2021
medline:
28
7
2022
entrez:
2
2
2021
Statut:
ppublish
Résumé
To support physical activity among people with systemic sclerosis (SSc [scleroderma]), we sought to determine the prevalence and importance of barriers and the likelihood of using possible facilitators. We invited 1,707 participants from an international SSc cohort to rate the importance of 20 barriers (14 medical, 4 social or personal, 1 lifestyle, and 1 environmental) and the likelihood of using 91 corresponding barrier-specific and 12 general facilitators. Among 721 respondents, 13 barriers were experienced by ≥25% of participants, including 2 barriers (fatigue and Raynaud's phenomenon) rated "important" or "very important" by ≥50% of participants, 7 barriers (joint stiffness and contractures, shortness of breath, gastrointestinal problems, difficulty grasping, pain, muscle weakness and mobility limitations, and low motivation) by 26-50%, and 4 barriers by <26%. Overall, 23 of 103 facilitators (18 medical-related) were rated by ≥75% of participants as "likely" or "very likely" to use among those who experienced corresponding barriers. These facilitators focused on adapting exercise (e.g., using controlled, slow movement), taking care of one's body (e.g., stretching), keeping warm (e.g., wearing gloves), and protecting skin (e.g., covering ulcers). Among those participants who had previously tried the facilitator, all facilitators were rated by ≥50% as "likely" or "very likely" to use. Among those participants with the barrier who had not tried the facilitator, only 12 of 103 facilitators were rated by >50% of participants as "likely" or "very likely" to use. Medical-related physical activity barriers were common and considered important. Facilitators considered as most likely to be used involved adapting exercise, taking care of one's body, keeping warm, and protecting skin.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1300-1310Subventions
Organisme : CIHR
ID : 157064
Pays : Canada
Informations de copyright
© 2021 American College of Rheumatology.
Références
Seibold JR. Scleroderma. In: Harris E, editor. Kelley's textbooks of rheumatology. 7th ed. Philadelphia: Elsevier; 2005. p. 1279-80.
Wigley FM. Clinical features of systemic sclerosis. In: Hochberg MC, editor. Rheumatology. 3rd ed. Philadelphia: Mosby; 2003. p. 1463-80.
Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, et al, for the Canadian Scleroderma Research Group. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 2009;61:1112-20.
Mayes MD. Systemic sclerosis: clinical features. In: Klippel JH, Stone JH, White PH, editors. Primer on the rheumatic diseases. New York: Springer Science & Business Media; 2008. p. 343-50.
Gelber AC, Manno RL, Shah AA, Woods A, Le EN, Boin F, et al. Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature. Medicine (Baltimore) 2013;92:191-205.
Reiner M, Niermann C, Jekauc D, Woll A. Long-term health benefits of physical activity: a systematic review of longitudinal studies. BMC Public Health 2013;13:813.
Warburton DE, Charlesworth S, Ivey A, Nettlefold L, Bredin SS. A systematic review of the evidence for Canada's physical activity guidelines for adults. Int J Behav Nutr Phys Act 2010;7:39.
Perandini LA, de Sá-Pinto AL, Roschel H, Benatti FB, Lima FR, Bonfá E, et al. Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases. Autoimmun Rev 2012;12:218-24.
Azar M, Rice DB, Kwakkenbos L, Carrier M, Shrier I, Bartlett SJ, et al. Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study. Disabil Rehabil 2018;40:1997-2003.
Battaglia S, Bellia M, Serafino-Agrusa L, Giardina A, Messina M, Cannizzaro F, et al. Physical capacity in performing daily activities is reduced in scleroderma patients with early lung involvement. Clin Respir J 2017;11:36-42.
Pettersson H, Åkerström A, Nordin A, Svenungsson E, Alexanderson H, Boström C. Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls. Scand J Rheumatol 2017;46:490-5.
Liem S, Meessen J, Wolterbeek R, Marsan NA, Ninaber M, Vlieland TV, et al. Physical activity in patients with systemic sclerosis. Rheumatol Int 2018;38:443-53.
Harb S, Cumin J, Rice DB, Peláez S, Hudson M, Bartlett SJ, et al. Identifying barriers and facilitators to physical activity for people with scleroderma: a nominal group technique study. Disabil Rehabil 2020:1-8.
Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-47.
Qualtrics. Provo U. Qualtrics survey platform. 2002.
Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Tudor-Locke C, et al. 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 2011;43:1575-81.
Kwakkenbos L, Thombs BD, Khanna D, Carrier M, Baron M, Furst DE, et al. Performance of the patient-reported outcomes measurement information system-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort study. Rheumatology (Oxford) 2017;56:1302-11.
Hinchcliff M, Beaumont JL, Thavarajah K, Varga J, Chung A, Podlusky S, et al. Validity of two new patient-reported outcome measures in systemic sclerosis: patient-reported outcomes measurement information system 29-item health profile and functional assessment of chronic illness therapy-dyspnea short form. Arthritis Care Res (Hoboken) 2011;63:1620-8.
Hinchcliff ME, Beaumont JL, Carns MA, Podlusky S, Thavarajah K, Varga J, et al. Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis. J Rheumatol 2015;42:64-72.
Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999;42:2372-80.
Lascar N, Kennedy A, Hancock B, Jenkins D, Andrews RC, Greenfield S, et al. Attitudes and barriers to exercise in adults with type 1 diabetes (T1DM) and how best to address them: a qualitative study. PLoS One 2014;9:e108019.
Process of translation and adaptation of instruments. 2020. URL: https://www.who.int/substance_abuse/research_tools/translation/en/.
Cuomo G, Santoriello C, Polverino F, Ruocco L, Valentini G, Polverino M. Impaired exercise performance in systemic sclerosis and its clinical correlations. Scand J Rheumatol 2010;39:330-5.
Morelli S, Ferrante L, Sgreccia A, Eleuteri ML, Perrone C, De Marzio P, et al. Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol 2000;29:236-42.
Salmon J, Owen N, Crawford D, Bauman A, Sallis JF. Physical activity and sedentary behavior: a population-based study of barriers, enjoyment, and preference. Health Psychol 2003;22:178.
Booth ML, Bauman A, Owen N, Gore CJ. Physical activity preferences, preferred sources of assistance, and perceived barriers to increased activity among physically inactive Australians. Prev Med 1997;26:131-7.
Jewett LR, Hudson M, Malcarne VL, Baron M, Thombs BD, Canadian Scleroderma Research Group. Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis. PloS One 2012;7:e33281.
Wigley FM, Flavahan NA. Raynaud's phenomenon. N Engl J Med 2016;375:556-65.
Richard M, Christina MF, Deborah LS, Rubio N, Kennon MS. Intrinsic motivation and exercise adherence. Int J Sport Psychol 1997;28:335-54.
Blaire SN, Dunn AL, Marcus BH, Carpenter RA, Jaret PE. Active Living Every Day, 3rd edition. Human Kinetics; 2021.
Pope JE. Management of fatigue in rheumatoid arthritis. RMD Open 2020;6:e001084.
Carrier ME, Kwakkenbos L, Nielson WR, Fedoruk C, Nielsen K, Milette K, et al. The Scleroderma Patient-centered Intervention Network self-management program: protocol for a randomized feasibility trial. JMIR Res Protoc 2020;9:e16799.
Kwakkenbos L, Thombs BD. Non-drug approaches to treating Raynaud's phenomenon. In: Raynaud's Phenomenon. New York: Springer; 2015. p. 299-313.
Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian national survey. Rheumatology 2011;50:762-7.
Kwakkenbos L, Carrier ME, Boutron I, Welling J, Sauvé M, van den Ende CH, et al. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND). J Rheumatol 2019;46:816.
Courneya KS, Plotnikoff RC, Hotz SB, Birkett NJ. Social support and the theory of planned behavior in the exercise domain. Am J Health Behav 2000;24:300-8.
Gumuchian ST, Delisle VC, Kwakkenbos L, Pépin M, Carrier ME, Malcarne VL, et al. Reasons for attending support groups and organizational preferences: the European scleroderma support group members survey. Disabil Rehabil 2019;41:974-82.
Godin G. The Godin-Shephard leisure-time physical activity questionnaire. Health & Fitness Journal of Canada 2011;4:18-22.
Amireault S, Godin G. The Godin-Shephard leisure-time physical activity questionnaire: validity evidence supporting its use for classifying healthy adults into active and insufficiently active categories. Percept Mot Skills 2015;120:604-22.